Development of a Berberine Loaded Multifunctional Design for the Treatment of Helicobacter pylori Induced Gastric Ulcer

Author(s): Sunil K. Jain*, Kamlesh Patel, Kuldeep Rajpoot, Akhlesh Jain.

Journal Name: Drug Delivery Letters

Volume 9 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background and Objective: The H. pylori infection causes chronic inflammation and significantly increases the risk of developing duodenal and gastric ulcer disease and gastric cancer. Infection with H. pylori is the well-known risk factor for gastric cancer. It is highly desirable to develop a delivery system that localizes the antibiotic at the site of infection to achieve bactericidal concentration for a longer period of time. Thus, present work aimed to develop Concanavalin-A (Con-A) conjugated gastro-retentive microspheres of polymethylmethacrylate (PMMA) and polyethylene oxide (PEO) containing berberine hydrochloride (BBR) for the treatment of H. pylori infection.

Methods: Microspheres were prepared by solvent evaporation method and characterized by particles size distribution, surface morphology, % drug entrapment and in vitro drug release in the simulated gastric fluid. Optimized microspheres were conjugated with Con-A and further characterized for Con-A conjugation efficiency, in vitro drug release and ex vivo mucoadhesive properties.

Results and Conclusion: Enhanced mucoadhesion (88±1.9%) was shown by Con-A conjugated microspheres as compared with non-conjugated microspheres (14.5±3.6%). This significant difference (p<0.05) in the mucoadhesion may be due to affinity of the Con-A towards glycoproteins of mucus membrane of stomach. Attachment of lectin (Con-A) to the microspheres significantly enhanced the mucoadhesiveness as well as also controlled the berberine release for 10 h study period. The preliminary results from this study advised that Con-A conjugated PMMA and PEO microspheres could be used to incorporate some more herbal drugs and may be used for oral administration against H. pylori in the stomach.

Keywords: H. pylori, berberine hydrochloride, polymethylmethacrylate, polyethylene oxide, Concanavalin-A, microspheres.

[1]
Prasanthi, C.H.; Prasanthi, N.L.; Manikiran, S.S.; Rao, N.N. Focus on current trends in the treatment of Helicobacter pylori infection: An update. Int. J. Pharm. Sci. Rev. Res., 2011, 9, 42-51.
[2]
Wroblewski, L.E.; Peek, R.M., Jr; Wilson, K.T. Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk. Clin. Microbiol. Rev., 2010, 23(4), 713-739.
[3]
Burne, R.A.; Chen, Y.M. Bacterial ureases in infectious diseases. Microbes Infect., 2000, 2, 533-542.
[4]
Rektorschek, M.; Weeks, D.; Sachs, G.; Melchers, K. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology, 1998, 115, 628-641.
[5]
Bayerdroffer, E.; Miehlk, S.; Mannes, A.; Sommer, A.; Hocker, W.; Weingart, J.; Heldwein, W.; Klann, H. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology, 1995, 108, 1412-1417.
[6]
Bell, G.D.; Powell, K.U.; Burridge, M.; Spenceer, G.; Bolton, G.; Purser, K.; Brooks, S. Omeprazole plus antimalarial combination for the eradication of metronidazole- resistant Helicobacter pylori. Aliment. Pharmacol. Ther., 1992, 6, 751-758.
[7]
Umamaheswari, R.B.; Jain, N.K. Receptor mediated targeting of lectin conjugated gliadin nanoparticle in the treatment of Helicobacter pylori. Drug Target., 2003, 11(7), 415-423.
[8]
Akiyama, Y.; Nagahara, N.; Nava, E.; Kitano, M.; Iwara, S.; Ogawa, Y.; Yammen, L.; Ajuma, J. Evaluation of oral mucoadhesive microspheres in man on the basis of pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J. Pharm. Pharmacol., 1998, 50, 159-166.
[9]
Borrebaeck, C.; Mattiasson, B. A study of structurally related binding properties of concanavalin A using differential scanning calorimetry. Eur. J. Biochem., 1980, 107, 67-71.
[10]
Russell-Jones, G.J.; Veitch, H.; Arthur, L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm., 1999, 190(2), 165-174.
[11]
Betton, G.R. Agglutination reactions of spontaneous canine tumour cells, induced by concanavalin A, demonstrated by an isotopic assay. Int. J. Cancer, 1976, 18(5), 687-696.
[12]
Kakizoe, T.; Komatsu, H.; Niijima, T.; Kawachi, T.; Sugimura, T. Increased agglutinability of bladder cells by concanavalin A after administration of carcinogens. Cancer Res., 1990, 40(6), 2006-2009.
[13]
Ramteke, S.; Umamaheswari, R.B.; Jain, N.K. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Indian J. Pharm. Sci., 2006, 68(4), 479-484.
[14]
Jain, S.K.; Haider, T.; Kumar, A.; Jain, A. Lectin conjugated clarithromycin and acetohydroxamic acid loaded PLGA nanoparticles: A novel approach for effective treatment of H. pylori. AAPS PharmSciTech, 2016, 17(5), 1131-1140.
[15]
Jain, S.K.; Prajapati, N.; Rajpoot, K.; Kumar, A. A novel sustained release drug resin complex based microbeads of ciprofloxacin HCl. Artif. Cells Nanomed. Biotechnol., 2016, 44(8), 1891-1900. b
[16]
Jain, S.K.; Gupta, M.; Sahoo, A.K.; Pandey, A.N.; Jain, A.K. Lectin conjugated gastro-retentive microspheres of amoxicillin for effective treatment of H. pylori. Curr. Sci., 2014, 106(2), 267-276.
[17]
Jain, S.K.; Jangde, M. Lectin conjugated gastro- retentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Mol. Pharm., 2009, 6(1), 295-304.
[18]
Birdsall, T.C.; Kelly, G.S. Berberine, therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev., 1997, 2, 94-103.
[19]
Sudhakar, K.; Rao, K.M.; Mallkarjuna, B.; Prasad, C.V.; Subha, M.C.S.; Rao, K.C. Preparation and characterization of nimesulide loaded poly (methyl methacrylate)/poly (ethylene oxide) blend microspheres, In vitro release studies. Asian J. Pharm., 2013, 7(3), 118-124.
[20]
Ponchel, G.; Irache, J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev., 1998, 34(2-3), 191-219.
[21]
Nakajima, N.; Ikada, Y. Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. Bioconjug. Chem., 1995, 6(1), 123-130.
[22]
Anande, N.; Jain, S.K.; Jain, N.K. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate. Int. J. Pharm., 2008, 359, 182-189.
[23]
Coppi, G.; Sala, N.; Bondi, M.; Sergi, S.; Iannuccelli, V. Ex-vivo evaluation of alginate microparticles for Polymyxin B oral administration. J. Drug Target., 2006, 14(9), 599-606.
[24]
Staros, J.V.; Wright, R.W.; Swingle, D.M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide mediated coupling reactions. Anal. Biochem., 1986, 156, 220-222.
[25]
Grabarek, Z.; Gergely, J. Zero-length crosslinking procedure with the use of active esters. Anal. Biochem., 1990, 185, 131-135.
[26]
Khin, M.M.; Hua, J.S.; Cong, H.N.; Wadstrm, T.; Ho, B. Agglutination of Helicobacter pylori coccoids by lectins. World J. Gastroenterol., 2006, 6(2), 202-209.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 1
Year: 2019
Page: [50 - 57]
Pages: 8
DOI: 10.2174/2210303108666181120110756
Price: $58

Article Metrics

PDF: 23
HTML: 1